Bandhan BSE Healthcare Index Fund Regular Growth is a mutual fund scheme from Bandhan Asset Management Company Limited. The fund was launched on 22 October 2024 and is managed by Mayuresh Nagvekar and Abhishek Jain. As of 15 October 2026, the fund has an AUM of ₹20.88 Cr and its latest NAV is ₹10.97. The fund has a Very High Risk risk rating.
The fund allows minimum SIP of ₹100 and lumpsum investment starting from ₹1,000.
The fund primarily invests in Healthcare and Basic Materials and its top holdings include Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Apollo Hospitals Enterprise Ltd, Laurus Labs Ltd, and Cipla Ltd. The fund has delivered 8.1% returns over the last 1 year and 5.4% annualised returns since inception.
Bandhan BSE Healthcare Index Fund Regular Growth may be suitable for investors looking for long-term wealth creation and who are comfortable with Very High Risk risk.






